» Articles » PMID: 18333188

Liver Cell Adenoma and Liver Cell Adenomatosis

Overview
Journal HPB (Oxford)
Publisher Elsevier
Specialty Gastroenterology
Date 2008 Mar 12
PMID 18333188
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

During the last three decades liver cell adenoma and liver cell adenomatosis have emerged as new clinical entities in hepato-logical practice due to the widespread use of oral contraceptives and increased imaging of the liver. On review of published series there is evidence that 10% of liver cell adenomas progress to hepatocellular carcinoma, diagnosis is best made by open or laparoscopic excision biopsy, and the preferred treatment modality is resection of the liver cell adenoma to prevent bleeding and malignant transformation. In liver cell adenomatosis, the association with oral contraceptive use is not as high as in solitary liver cell adenomas. The risk of malignant transformation is not increased compared with solitary liver cell adenomas. Treatment consists of close monitoring and imaging, resection of superficially located, large (>4 cm) or growing liver cell adenomas. Liver transplantation is the last resort in case of substantive concern about malignant transformation or for large, painful adenomas in liver cell adenomatosis after treatment attempts by liver resection.

Citing Articles

Androgen-Induced, β-Catenin-Activated Hepatocellular Adenomatosis with Spontaneous External Rupture.

Huang J, Ali T, Feldman D, Theise N Diagnostics (Basel). 2024; 14(14).

PMID: 39061609 PMC: 11276095. DOI: 10.3390/diagnostics14141473.


Case Report: Hepatic Adenomatosis in a Patient With Prader-Willi Syndrome.

Dauleh H, Soliman A, Haris B, Khalifa A, Al Khori N, Hussain K Front Endocrinol (Lausanne). 2022; 13:826772.

PMID: 35355562 PMC: 8959895. DOI: 10.3389/fendo.2022.826772.


Hepatic Adenomatosis in a Young Asymptomatic but High-risk Patient: An Incidental Diagnosis with Potentially Severe Clinical Implications.

Lanza D, Bilali M Eur J Case Rep Intern Med. 2021; 8(11):002999.

PMID: 34912742 PMC: 8668000. DOI: 10.12890/2021_002999.


HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI.

Auer T, Walter-Rittel T, Geisel D, Schoning W, Schmelzle M, Muller T BMC Med Imaging. 2021; 21(1):28.

PMID: 33588783 PMC: 7885421. DOI: 10.1186/s12880-021-00552-0.


Unclassified hepatocellular adenoma with beta-catenin mutation: a case report.

Muranushi R, Araki K, Harimoto N, Yokobori T, Hoshino K, Hagiwara K Surg Case Rep. 2021; 7(1):46.

PMID: 33580445 PMC: 7881073. DOI: 10.1186/s40792-021-01131-9.


References
1.
Van Hoe L, Baert A, Gryspeerdt S, Vandenbosh G, Nevens F, Van Steenbergen W . Dual-phase helical CT of the liver: value of an early-phase acquisition in the differential diagnosis of noncystic focal lesions. AJR Am J Roentgenol. 1997; 168(5):1185-92. DOI: 10.2214/ajr.168.5.9129409. View

2.
. Terminology of nodular hepatocellular lesions. Hepatology. 1995; 22(3):983-93. DOI: 10.1016/0270-9139(95)90324-0. View

3.
Ramji A, Yoshida E, Bain V, Kneteman N, Scudamore C, Ma M . Late acute rejection after liver transplantation: the Western Canada experience. Liver Transpl. 2002; 8(10):945-51. DOI: 10.1053/jlts.2002.34969. View

4.
Scott F, El-Refaie A, More L, Scheuer P, Dhillon A . Hepatocellular carcinoma arising in an adenoma: value of QBend 10 immunostaining in diagnosis of liver cell carcinoma. Histopathology. 1996; 28(5):472-4. DOI: 10.1046/j.1365-2559.1996.t01-3-297345.x. View

5.
Reddy K, Kligerman S, Levi J, Livingstone A, Molina E, Franceschi D . Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg. 2001; 67(2):173-8. View